Trade IMDX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Insight Molecular Diagnostics Inc. (IMDX) is trading at US$4.13, down 3.73% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$142.02M. Over the past 52 weeks, IMDX has traded between US$2.40 and US$8.51. On Syfe you can trade IMDX with $0 commission and add it to your watchlist.
| Previous close | US$4.29 |
|---|---|
| Market cap | US$142.02M |
| 52-week range | US$2.40 – US$8.51 |
| Volume | 81.04K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The company was founded in September 2009 and is headquartered in Nashville, TN.
Year: 2015
Insight Molecular Diagnostics Inc. (IMDX) stock is trading at US$4.13, -3.73% from the previous close of US$4.29.
The market cap for Insight Molecular Diagnostics Inc. (IMDX) stock is approximately US$142.02M.
The 52-week high for Insight Molecular Diagnostics Inc. (IMDX) stock is US$8.51.
The 52-week low for Insight Molecular Diagnostics Inc. (IMDX) stock is US$2.40.
Insight Molecular Diagnostics Inc. (IMDX) does not currently pay a dividend.
Stay on top of IMDX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
